TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
äŒæ¥ã³ãŒãTXMD
äŒç€ŸåTherapeuticsMD Inc
äžå Žæ¥Jan 31, 2001
æé«çµå¶è²¬ä»»è
ãCEOãWalker (Marlan D)
åŸæ¥å¡æ°1
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jan 31
æ¬ç€Ÿæåšå°951 Yamato Road, Suite 220
éœåžBOCA RATON
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·33431
é»è©±çªå·15619611900
ãŠã§ããµã€ãhttps://www.therapeuticsmd.com/
äŒæ¥ã³ãŒãTXMD
äžå Žæ¥Jan 31, 2001
æé«çµå¶è²¬ä»»è
ãCEOãWalker (Marlan D)